Found: 11
Select item for more details and to access through your institution.
2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S74, doi. 10.1093/ofid/ofz359.160
- By:
- Publication type:
- Article
ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33649-3
- By:
- Publication type:
- Article
First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2073, doi. 10.1093/cid/ciz653
- By:
- Publication type:
- Article
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e353, doi. 10.1093/infdis/jiad560
- By:
- Publication type:
- Article
Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 11, p. 1491, doi. 10.1093/infdis/jiad182
- By:
- Publication type:
- Article
Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
- Published in:
- Journal of Infectious Diseases, 2018, v. 217, n. 10, p. 1616, doi. 10.1093/infdis/jiy065
- By:
- Publication type:
- Article
Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.
- Published in:
- 2017
- By:
- Publication type:
- journal article